Literature DB >> 28404667

Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients.

Huanfen Zhou1,2, Quangang Xu1, Shuo Zhao3, Wei Wang4, Junqing Wang1, Zhiye Chen5, Dahe Lin6, Xiaoming Li1, Chunxia Peng1, Nanping Ai1, Shihui Wei1.   

Abstract

OBJECTIVE: To evaluate the clinical features and prognosis of atypical optic neuritis (ON) with seronegative aquaporin-4 (AQP4) antibody in Chinese patients.
METHODS: All patients with first or relapsing ON were recruited from the Neuro-ophthalmology Department of the Chinese People's Liberation Army General Hospital from January 2013 to December 2014 and assigned to one of three groups based on diagnosis: atypical ON, typical ON and neuromyelitis optica spectrum disorder (NMOSD)-ON.
RESULTS: A total of 173 patients were included in the cohort. Fifty patients (28.9%) were AQP4-Ab-positive and diagnosed with NMOSD-ON. Of 123 patients with seronegative AQP4-Ab, 37 (30.1%) patients had atypical ON, with male predominance (25, 67.6%). The atypical ON group (compared with the typical ON and NMOSD-ON groups) had a significantly lower female:male ratio (1:2.1 vs 1.8:1 and 9:1, respectively, p=0.001 and p<0.001), an older mean age of onset (44.8, 13-71 years vs 36.9, 13-73 years and 36.2, 13-66 years, p=0.003 and p=0.004), a lower rate of good (≥0.5) visual recovery (6.7% vs 79.8% and 30.9%, p<0.001 and p<0.001) and (compared with the NMOSD-ON group) a lower recurrence rate during a 2-year follow-up (29.3% vs 60%, p=0.009). However, none developed to multiple sclerosis or neuromyelitis optica in the atypical ON group.
CONCLUSIONS: Atypical ON with seronegative AQP4-Ab had unique clinical features in this Chinese cohort, including male predominance, an older age of onset, worse visual acuity recovery and resistance to corticosteroid therapy. This condition may be a distinct nosological entity with an unusual clinical and therapeutic profile. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Optic neuritis; aetiology; multiple sclerosis; neuromyelitis optica; prevalence

Mesh:

Substances:

Year:  2017        PMID: 28404667     DOI: 10.1136/bjophthalmol-2017-310157

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial.

Authors:  Wenjing Luo; Xinlei Deng; Xiaoyu Xu; Ruitong Song; Meifeng Luo; Heather E Moss; Yi Du
Journal:  J Neuroophthalmol       Date:  2021-10-22       Impact factor: 4.415

2.  Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China.

Authors:  Honglu Song; Huanfen Zhou; Mo Yang; Junqing Wang; Hongjuan Liu; Mingming Sun; Quangang Xu; Shihui Wei
Journal:  J Ophthalmol       Date:  2019-04-01       Impact factor: 1.909

3.  Optic Neuritis in the Older Chinese Population: A 5-Year Follow-Up Study.

Authors:  Junqing Wang; Huanfen Zhou; Limin Qin; Chunxia Peng; Jie Zhao; Da Teng; Dahe Lin; Nanping Ai; Quangang Xu; Shihui Wei
Journal:  J Ophthalmol       Date:  2017-12-11       Impact factor: 1.909

4.  Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis.

Authors:  Linda Hansapinyo; Chayanee Vivattanaseth
Journal:  Open Ophthalmol J       Date:  2018-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.